Article

Light-adjustable IOL may allow for fine-tuning after implantation

Lisbon, Portugal—Accurate adjustment of the new Light Adjustable Intraocular Lens (LAL) (Calhoun Vision) after implantation is possible using new digital light delivery systems and may eliminate the need for explantation of the IOL because of incorrect lens power after cataract surgery, reported Nick Mamalis, MD, at the annual meeting of the European Society of Cataract and Refractive Surgeons.

What makes adjustment of the LAL possible is the new Digital Light Delivery Device, which was designed and manufactured by Carl Zeiss Meditec AG. It allows customization of the lens correction, precise correction of astigmatism, and even a possible wavefront pattern of light delivery. The instrument is a modified slit-lamp that has a digital chip with 1.3 million microscopic mirrors. The device is installed and serviced by Carl Zeiss Meditec; the system and software are sold by Calhoun Vision.

"The Light Delivery Device is mounted on a conventional slit lamp. The refractive error and desired refractive outcome are entered on the color console and irradiation is activated using either a foot pedal or joy stick," Dr. Mamalis explained.

"Accurate IOL power adjustments were possible using the new Digital Light Delivery system in terms of myopic, hyperopic, and astigmatic correction in clinical studies performed by Dr. Arturo Chayet in Mexico," Dr. Mamalis reported (Figure 1).

How the technology works

Dr. Mamalis described how the LAL is fine-tuned using the Light Delivery Device after implantation of the IOL.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.